PMID: 2508649Jun 1, 1989Paper

Sodium cromoglycate: a review

The European Respiratory Journal. Supplement
F Patalano, F Ruggieri

Abstract

Sodium cromoglycate is a drug widely used in the treatment of bronchial asthma. In vitro and animal models show that its effect is related to mast cell stabilization and to a direct action on inflammatory cells or the broncho-obstructive reflex. In man, sodium cromoglycate is able to prevent bronchoconstriction induced by a variety of stimuli including the 'late' reaction to allergen. It is also able to prevent the allergen-induced increase in hyperresponsiveness. Long-term therapeutic trials have confirmed its validity in the treatment of asthmatic patients.

Related Concepts

Related Feeds

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.

Asthma

This feed focuses in Asthma in which your airways narrow and swell. This can make breathing difficult and trigger coughing, wheezing and shortness of breath.

Related Papers

Therapia Hungarica : Hungarian Medical Journal
G Zsámboki
Schweizerische medizinische Wochenschrift
M Solèr
Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego
Jadwiga Kroczyńska-Bednarek, Iwona Grzelewska-Rzymowska
© 2022 Meta ULC. All rights reserved